HCXY — Hercules Capital Inc stock price, charts and financials

NYSE·Financial Services·Financial - Credit Services·USA

Latest market price

25.06

+0.06+0.24%

Overview Short InterestFilings

HCXYQT54Hercules Capital Inc·NYSE

Overview Short InterestFilings

25.06+0.24%

Loading chart...

Screen all →

UPST+7.25%$29.43 AGM+4.55%$237.96 LC+1.73%$19.95 BFH+2.53%$110.80 WU+2.99%$6.55 JSM+0.80%$17.62 NNI+1.75%$138.25 SLM+4.23%$27.10

Snapshot

Index	-	P/E	7.86	EPS (ttm)	3.18	Insider Own	3.03%	Shs Outstand	140.96M	Perf Week	1.17%

Market Cap	3.07B	Forward P/E	12.59	EPS next Y	1.98	Insider Trans	4.22%	Shs Float	138.35M	Perf Month	0.20%

Enterprise Value	3.04B	PEG	0.21	EPS next Q	-	Inst Own	-	Short Float	0.01%	Perf Quarter	0.81%

Income	255.32M	P/S	5.60	EPS this Y	10.38%	Inst Trans	-	Short Ratio	4.22	Perf Half Y	-1.11%

Sales	548.69M	P/B	1.34	EPS next Y	1.60%	ROA	5.40%	Short Interest	13.04K	Perf YTD	-1.92%

Book/sh	-	P/C	33.44	EPS next 5Y	-2.16%	ROE	11.36%	52W High	25.77 -2.76%	Perf Year	-0.40%

Cash/sh	-	P/FCF	33.75	EPS past 3/5Y	32.79% -1.65%	ROIC	347.86%	52W Low	24.42 2.63%	Perf 3Y	0.40%

Dividend Est.	1.56 (6.23%)	EV/EBITDA	8.85	Sales past 3/5Y	31.78% 8.91%	Gross Margin	86.56%	Volatility	0.67% 0.49%	Perf 5Y	-7.20%

Dividend TTM	1.56 (6.23%)	EV/Sales	5.54	EPS Y/Y TTM	9.94%	Oper. Margin	62.52%	ATR (14)	0.16	Perf 10Y	-

Dividend Ex-Date	Jul 15, 2026	Quick Ratio	5.71	Sales Y/Y TTM	27.84%	Profit Margin	46.11%	RSI (14)	56.85	Recom	-

Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	5.71	EPS Q/Q	-48.89%	SMA20	0.63%	Beta	0.17	Target Price	-

Payout	132.56%	Debt/Eq	0.01	Sales Q/Q	4.35%	SMA50	0.30%	Rel Volume	3.15	Prev Close	25.00

Employees	108	LT Debt/Eq	1.04	Earnings	Nov 04	SMA200	-0.58%	Avg Volume	3.10K	Price	25.06

IPO Date	Sep 27, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-52.01% -12.55%	Net Debt/EBITDA	-0.10	Volume	9,766	Change	0.24%

Latest News

Jul-30-26

Jul-30-2611:55AM

Ares Capital: 20 Big-Yield BDCs Ranked For A Maturing MarketSeekingAlpha

Company

Hercules Capital, Inc. is a business development company. It focuses on venture lending capital-backed companies in the technology and life science industries. The company was founded in December 2003 and is headquartered in San Mater, CA.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	551	547	431	494	239	310	357	298	176
Cost of Goods Sold Incl. D&A	78	70	77	68	55	54	60	55	39
Gross Profit	473	477	354	426	185	255	298	244	136
Selling, General and Administrative Excl. Other	19	19	20	19	17	16	19	19	15
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	95	93	71	70	66	65	52	51	45
Operating Income	358	365	263	337	102	174	227	174	76
Interest Expense	100	92	77	68	55	54	60	55	39
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	75	67	77	68	55	54	60	55	39
Net Income Before Taxes	333	340	263	337	102	174	227	174	76
Income Taxes	0	0	0	0	0	0	0	0	0
Consolidated Net Income	333	340	263	337	102	174	227	174	76
Net Income From Continuing Operations	333	340	263	337	102	174	227	174	76
Net Income	333	340	263	337	102	174	227	174	76
EPS (Recurring)	1.83	1.90	1.61	2.32	0.80	1.50	2.02	1.71	0.83
EPS (Basic, Before Extraordinaries)	1.83	1.90	1.61	2.32	0.80	1.50	2.02	1.71	0.83
EPS (Diluted)	1.77	1.85	1.61	2.31	0.79	1.49	2.01	1.71	0.83
EBITDA	358	365	263	338	102	174	228	174	77
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	14.16	13.78	15.63	10.93	31.13	17.90	13.33	15.41	28.13
Price To Sales Ratio	8.32	8.43	9.40	7.36	12.86	9.89	8.41	8.93	12.07
Gross Margin	85.84	87.20	82.13	86.23	77.41	82.26	83.47	81.88	77.27
Operating Margin	64.97	66.73	61.02	68.22	42.68	56.13	63.59	58.39	43.18
Net Margin	60.44	62.16	61.02	68.22	42.68	56.13	63.59	58.39	43.18
Shares Outstanding	183	181	161	144	125	115	112	101	91
Market Capitalization	4,586	4,614	4,052	3,636	3,074	3,067	3,002	2,661	2,125
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BADAVAS ROBERT P	Director	Mar 26 '26	Buy	14.35	3,658	52,492	5,070	Mar 30
Loo Wade	Director	Mar 26 '26	Buy	14.35	7,317	104,999	14,050	Mar 30
Fallon Thomas J	Director	Mar 26 '26	Buy	14.30	7,300	104,390	157,669	Mar 30
Aguirre DeAnne	Director	Mar 26 '26	Buy	14.35	7,317	104,999	10,749	Mar 30
Randhawa Paramjeet K	Director	Mar 26 '26	Buy	14.35	2,926	41,988	22,486	Mar 30
CROWELL GAYLE A	Director	Mar 26 '26	Buy	14.35	7,317	104,999	97,589	Mar 30
Theodosopoulos Nikos	Director	Mar 26 '26	Buy	14.35	7,317	104,999	29,362	Mar 30
Follmann Christian	Chief Operating Officer	Mar 04 '26	Buy	14.68	10,000	146,800	150,135	Mar 05
Randhawa Paramjeet K	Director	Mar 04 '26	Buy	14.78	3,050	45,079	19,560	Mar 05
BADAVAS ROBERT P	Director	Feb 27 '26	Buy	14.27	5,000	71,350	122,073	Feb 27
Botelho Kiersten Zaza	Chief Legal Officer & CCO	Feb 27 '26	Buy	14.21	1,300	18,473	93,336	Feb 27
Fallon Thomas J	Director	Feb 27 '26	Buy	14.20	20,000	284,000	150,369	Feb 27
Theodosopoulos Nikos	Director	Feb 27 '26	Buy	14.21	2,600	36,946	21,523	Feb 27
Meyer Seth H	Chief Financial Officer	Feb 27 '26	Buy	14.33	7,000	100,310	448,553	Feb 27
Bluestein Scott	Chief Executive Officer	Feb 27 '26	Buy	14.35	7,000	100,450	2,516,379	Feb 27

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.